effects of virtual rehabilitation on upper extremity motor learning in hemiplegic cerebral palsy

Not Applicable

Conditions: G80.9
Cerebral palsy is a prevalent neurodevelopmental disorder that ranging from 1.5 to 2.5/1000 births beginning in the early childhood and continues throughout life. It causing the non-progressive disturbance of motor function that influences posture and movement, motor coordination with secondary complications of contractures and bone deformity. These alternations leading to hindrance in independent performance of daily activities.
Cerebral palsy, unspecified

Registration Number: IRCT20220616055192N1

Lead Sponsor: The university of Faisalabad

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: All

Target Recruitment: 25

Inclusion Criteria

Patients between 5 to 10 years old
Diagnosed as hemiplegic cerebral palsy
Both genders will include
Being able to cooperate and being motivated will include in the study
Patients who are able to understand and clearly follow verbal instructions and command that include in training and evaluation.
Patients with Gross Motor Function Classification Scale level 1, 2 and 3 will include

Exclusion Criteria

Patients with visual impairments and auditory problem
Patients with severe spasticity (Modified Ashworth spasticity score of 4) excluded from the study
Patients with Psychological illness
Participants Suffered from uncontrolled seizures
Patients injected with Botulinum toxin injections within past three months were excluded
Patients having prior surgery for spasticity within past 3 months were excluded from study

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Spasticity and impaired range of motion in the upper extremity. Timepoint: motor function will be measured at start of treatment sessions and after eight weeks after treatment sessions finished. Method of measurement: modified ashworth scale will use.;Motor dysfunction in the upper limb. Timepoint: motor function will be measured at start of treatment sessions and after eight weeks after treatment sessions finished. Method of measurement: ABILHAND - KIDS and PMAL scale will use.

Secondary Outcome Measures